Cargando…
LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies
BACKGROUND: LMNA mutations are most frequently involved in the pathogenesis of dilated cardiomyopathy with conduction disease. The goal of this study was to identify LMNA mutations, estimate their frequency among Polish dilated cardiomyopathy patients and characterize their effect both in vivo and i...
Autores principales: | Saj, Michal, Bilinska, Zofia T, Tarnowska, Agnieszka, Sioma, Agnieszka, Bolongo, Pierrette, Sobieszczanska-Malek, Malgorzata, Michalak, Ewa, Golen, Dorota, Mazurkiewicz, Lukasz, Malek, Lukasz, Walczak, Ewa, Fidzianska, Anna, Grzybowski, Jacek, Przybylski, Andrzej, Zielinski, Tomasz, Korewicki, Jerzy, Tesson, Frederique, Ploski, Rafal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666888/ https://www.ncbi.nlm.nih.gov/pubmed/23702046 http://dx.doi.org/10.1186/1471-2350-14-55 |
Ejemplares similares
-
The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation
por: Franaszczyk, Maria, et al.
Publicado: (2014) -
Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?
por: Chmielewski, Przemyslaw, et al.
Publicado: (2020) -
Titin Truncating Variants in Dilated Cardiomyopathy – Prevalence and Genotype-Phenotype Correlations
por: Franaszczyk, Maria, et al.
Publicado: (2017) -
A novel truncating variant in the LAMP2 gene in a young woman with hypertrophic cardiomyopathy and variable clinical course in the family
por: Michalak, Ewa, et al.
Publicado: (2019) -
A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations
por: Truszkowska, Grażyna T, et al.
Publicado: (2015)